The Life Sciences Web Portal for German-speaking Europe
This is a free web portal for the life sciences in German-speaking Europe... » read more
- Riboxx GmbH Licenses TLR3-Ligand RnD Programme to Tollys SAS (2016-02-04)
RIBOXX PHARMACEUTICALS, a biotech company developing Toll-like-receptor (TLR) and RIG-I-like-Receptor (RLR) ligands, and TOLLYS SAS, a biotech company developing new therapeutic strategies in cancer, today announced that they have signed a license agreement that gr...
- Curetis Expands Commercial Team, Appoints Head of Sales EMEA (2016-02-03)
Curetis N.V. (the "Company" and, together with Curetis AG, "Curetis"), a developer of next-level molecular diagnostic solutions, today announced the expansion of its commercial and general administrative team. As of February 1, 2016, Willem Haagmans has joined t...
- Medicxi Ventures Launches with €210m Closing of MV1 Fund (2016-02-03)
> Medicxi Ventures comprises all of the existing life sciences team, portfolio company investments and life sciences funds of Index Ventures > GSK and Johnson & Johnson Innovation expand their commitment to the asset-centric approach > Index Ventures technolo...
- ChemChina Cash Offer to Acquire Syngenta Valued over $43b (2016-02-03)
> Cash offer at US$ 465 per share plus special dividend of CHF 5 - offer equivalent to CHF 480 per share1 - proposed ordinary dividend of CHF 11 to be paid in addition > New shareholder will enable strategic continuity and long-term investment in innov...
- Evonik Partners with Institute of Chemical Technology Mumbai (2016-02-03)
Evonik Industries and the Institute of Chemical Technology, Mumbai have sealed a strategic partnership agreement for the purpose of exploring research topics together, closely in selected fields in the future. Evonik and ICT research partnership agreement includ...
- Xeltis Appoints Paul van Hagen as CFO (2016-02-02)
Xeltis has bolstered its executive team with the appointment of Paul van Hagen as Chief Financial Officer. Van Hagen joins Xeltis with over 20 years of experience as a financial professional, working for private and public healthcare companies. In his previous role...
- Mission Therapeutics Raises £60m to Advance DUB Inhibitors (2016-02-02)
Woodford Patient Capital Trust joins existing syndicate supporting transition to clinical development MISSION Therapeutics, a drug discovery and development company focused on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative a...
- Qiagen Announces New Bioinformatics Agreements (2016-02-02)
FDA centers and researchers gain access to QIAGEN’s enhanced solutions for applications including microbial and microbiome analysis QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced new partnerships to enhance the profile and expand the...
- CosmosID Partners with Qiagen for Microbial Analysis (2016-02-02)
CosmosID, a leading genomic big data company, today announced a partnership with QIAGEN (NASDAQ:QGEN) to launch its metagenomics analysis platform in QIAGEN’s CLC Genomics Workbench. This will complete the comprehensive metagenomics application offered in QIAGEN’s ...
- Evotec Awarded Grant from The Michael J. Fox Foundation (2016-02-02)
Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that it has been awarded a research grant from The Michael J. Fox Foundation ("MJFF") to further develop Evotec's TargetaSN (Targetalpha-synuclein) programme for the treatment of ...
Life-Sciences-Germany.com is your doorway to the life sciences in German-speaking Europe!
[LSG] provides free, up-to-date and structured access to
in Germany, Austria and Switzerland.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSG] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to email@example.com and simply fill the subject line with the word »LSG newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)